Board of Novartis India approves change in directorate
Mumbai, Feb. 17 -- The Board of Novartis India at its meeting held on 17 February 2024 has approved the appointment of Gira Sardesai (DIN: 02610502), as an Additional Director (designated as Non-Executive and Independent Director) with effect from 31 March 2024. The Board also took note of cessation of Jai Hiremath (DIN: 00062203) as an Independent Director of the company on completion of his second and final term with effect from 31 March 2024.
The Board has also appointed Christopher Snook (DIN: 00369790), as Non-Executive and Non-Independent Director for a period of 4 (four) consecutive years with effect from 31 March 2024.
Published by HT Digital Content Services with permission from Capital Market....
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.